Aerolase launches the Exci308 to help fight common skin conditions.
Aerolase announced the launch of its new device in fighting common skin conditions in patients with skin of color. The Exci308 is a handheld phototherapy device that addresses such autoimmune conditions including vitiligo, atopic dermatitis, psoriasis, scalp psoriasis, and leukoderma.1 Chesahna Kindred, MD, chair of the National Medical Association dermatology section, said, “I can now provide safe and effective phototherapy for a variety of conditions using a handheld device.”
The energy-based Aerolase Exci308 utilizes 308nm light to normalize skin affected by autoimmune diseases, such as inducing migration of the melanocytes on the border of depigmented areas in vitiligo. The Exci308 differs from other devices in price, size and weight, and speed. Aerolase touts it as a more affordable and less expensive option to treat autoimmune skin conditions, with equal efficacy and quicker treatment times.
Aerolase develops and manufactures portable high-power devices for dermatology and aesthetics applications.2. The company will seek clearance from the US Food and Drug Administration (FDA) for alopecia areata in 2023.
1. Aerolase, 2022. Aerolase Furthers its Treatment Range for Light-based Therapy in Skin of Color.
2. Aerolase extends treatment range for its universal skin laser technology. MedEsthetics.